ResearcherTianjin Medical University Cancer Institute and HospitalActive in the last 2 years

Yi Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6109-5347; OpenAlex author ID A5100330435. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2026: 1 paper

Papers 1

Sequential nimotuzumab plus gemcitabine and nab-paclitaxel chemotherapy followed by irreversible electroporation in advanced pancreatic ductal adenocarcinoma: … Co-author DOI 10.20892/j.issn.2095-3941.2025.0848 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yong Xu · 1 shared paper, 2026 · strength 0.26
- Paper Sequential nimotuzumab plus gemcitabine and nab-paclitaxel chemotherapy followed by irreversible electroporation in adv… DOI 10.20892/j.issn.2095-3941.2025.0848 ↗
Tongguo Si · 1 shared paper, 2026 · strength 0.26
- Paper Sequential nimotuzumab plus gemcitabine and nab-paclitaxel chemotherapy followed by irreversible electroporation in adv… DOI 10.20892/j.issn.2095-3941.2025.0848 ↗
Chuntao Gao · 1 shared paper, 2026 · strength 0.26
- Paper Sequential nimotuzumab plus gemcitabine and nab-paclitaxel chemotherapy followed by irreversible electroporation in adv… DOI 10.20892/j.issn.2095-3941.2025.0848 ↗
Jihui Hao · 1 shared paper, 2026 · strength 0.26
- Paper Sequential nimotuzumab plus gemcitabine and nab-paclitaxel chemotherapy followed by irreversible electroporation in adv… DOI 10.20892/j.issn.2095-3941.2025.0848 ↗
Hao Wang · 1 shared paper, 2026 · strength 0.26
- Paper Sequential nimotuzumab plus gemcitabine and nab-paclitaxel chemotherapy followed by irreversible electroporation in adv… DOI 10.20892/j.issn.2095-3941.2025.0848 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.